<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Pregnancy and Childbirth - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcpregnancychildbirth/</link>
		<description>The latest articles from BMC Pregnancy and Childbirth (ISSN 1471-2393) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/23"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/22"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/21"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/20"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/19"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/18"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/17"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/16"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/8/14"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/23">
            
            <title>Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants  </title>
			<description>Background:
Pregnancy in Type 1 diabetic patients is a precarious condition, both for mother and fetus with increased the risk of prematurity and, immediately after delivery with risk of respiratory distress syndrome and hypoglycaemia in newborns. A strict control and monitoring of diabetes throughout pregnancy is important in reducing the impact of the disease on the fetus and newborn. In recent years many new technologies have been introduced to ameliorate diabetes monitoring, where the last is the Real-time Continuous Glucose Monitoring System (RT-CGMS). 
Methods:
In the last three years, 72h continuous glucose monitoring system (RT-CGMS) (Medtronic, CA)  was performed in 18 pregnant women with Type 1 diabetes in two moments of pregnancy: during treatment with betamethasone to prevent respiratory distress and during delivery. In both cases insulin was administered intravenous and the dose was changed on the basis of glycaemia. 
Results:
The results present the use of this new technique during two topics moments of pregnancy of type 1 diabetes patients when is very important intensively to monitor diabetes and to obtain the well being of the fetus. No infant experimented hypoglycaemia or respiratory distress syndrome at the moment and in the first hours after the birth. 
Conclusions:
We wish to stress the importance reducing glycaemia during administration of betamethasone and during labor. It is conceivable that the scarce attention paid to monitoring glucose levels in diabetic mothers during labor in gynaecological world may be due to the difficulty in glucose monitoring with the devices until now available. Hopefully, our anecdotal account may prompt improvements with RT-CGMS, and may lead to a better approach to the problem, thereby changing the prognosis of infants born to diabetic mothers.</description>
			<link>http://www.biomedcentral.com/1471-2393/8/23</link>
			
			 	<dc:creator>Dario Iafusco, Fabrizio Stoppoloni, Gennaro Salvia, Gilberto Vernetti, Patrizia Passaro, Goran Petrovski and Francesco Prisco</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:23</dc:source>
			<dc:date>2008-07-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-23</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>23</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/22">
            
            <title>The design, implementation and acceptability of an integrated intervention to address multiple behavioral and psychosocial risk factors among pregnant African American women</title>
			<description>Background:
African American women are at increased risk for poor pregnancy outcomes compared to other racial-ethnic groups. Single or multiple psychosocial and behavioral factors may contribute to this risk. Most interventions focus on singular risks. This paper describes the design, implementation, challenges faced, and acceptability of a behavioral counseling intervention for low income, pregnant African American women which integrated multiple targeted risks into a multi-component format. 
Methods:
Six academic institutions in Washington, DC collaborated in the development of a community-wide, primary care, research study, DC-HOPE, to improve pregnancy outcomes. Cigarette smoking, environmental tobacco smoke exposure (ETSE), depression and intimate partner violence were the four risks targeted because of their adverse impact on pregnancy. Evidence-based models for addressing each risk were adapted and integrated into a multiple risk behavioral intervention format. Pregnant women attending six urban prenatal clinics were screened for eligibility and risks and randomized to intervention or usual care.  The 10-session intervention was delivered in conjunction with prenatal and postpartum care visits. Descriptive statistics on risk factor distributions, intervention attendance and length (i.e., with &lt; 4 sessions considered minimal adherence) for all enrolled women (n=1,044), and perceptions of study participation from a subsample of those enrolled (n=152) are reported.  
Results:
Forty-eight percent of women screened were eligible, 76% of those eligible were enrolled, and 79% of those enrolled were retained postpartum. Most women reported a single risk factor (61%); 39% had multiple risks. Eighty-four percent of intervention women attended at least one session (60% attended 4 or more sessions) without disruption of clinic scheduling. Specific risk factor content was delivered as prescribed in 80% or more of the sessions; 78% of sessions were fully completed (where all required risk content was covered). Over 90% of the subsample of women was satisfied with study participation. Most intervention women found the session content helpful. Implementation challenges of addressing multiple risk behaviors are discussed.
Conclusions:
While implementation adjustments and flexibility are necessary, multiple risk behavioral interventions can be implemented in a prenatal care setting without significant disruption of services, and with a majority of referred African American women participating in and expressing satisfaction with treatment sessions. </description>
			<link>http://www.biomedcentral.com/1471-2393/8/22</link>
			
			 	<dc:creator>Kathy S Katz, Susan M Blake, Renee A Milligan, Phyllis W Sharps, Davene B White, Margaret F Rodan, Maryann Rossi and Kennan B Murray</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:22</dc:source>
			<dc:date>2008-06-25</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-22</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>22</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/21">
            
            <title>Acceptability of evidence-based neonatal care practices in rural Uganda -implications for programming</title>
			<description>Background:
Although evidence-based interventions to reach the Millennium Development Goals for Maternal and Neonatal mortality reduction exist, they have not yet been operationalised and scaled up in Sub-Saharan African cultural and health systems. A key concern is whether these internationally recommended practices are acceptable and will be demanded by the target community. We explored the acceptability of these interventions in two rural districts of Uganda.
Methods:
We conducted 10 focus group discussions consisting of mothers, fathers, grand parents and child minders (older children who take care of other children). We also did 10 key informant interviews with health workers and traditional birth attendants.
Results:
Most maternal and newborn recommended practices are acceptable to both the community and to health service providers. However, health system and community barriers were prevalent and will need to be overcome for better neonatal outcomes. Pregnant women did not comprehend the importance of attending antenatal care early or more than once unless they felt ill. Women prefer to deliver in health facilities but most do not do so because they cannot afford the cost of drugs and supplies which are demanded in a situation of poverty and limited male support. Postnatal care is non-existent. For the newborn, delayed bathing and putting nothing on the umbilical cord were neither acceptable to parents nor to health providers, requiring negotiation of alternative practices.
Conclusions:
The recommended maternal-newborn practices are generally acceptable to the community and health service providers, but often are not practiced due to health systems and community barriers. Communities associate the need for antenatal care attendance with feeling ill, and postnatal care is non-existent in this region. Health promotion programs to improve newborn care must prioritize postnatal care, and take into account the local socio-cultural situation and health systems barriers including the financial burden. Male involvement and promotion of waiting shelters at selected health units should be considered in order to increase access to supervised deliveries. Scale-up of the evidence based practices for maternal-neonatal health in Sub-Saharan Africa should follow rapid appraisal and adaptation of intervention packages to address the local health system and socio-cultural situation. </description>
			<link>http://www.biomedcentral.com/1471-2393/8/21</link>
			
			 	<dc:creator>Peter Waiswa, Margaret Kemigisa, Juliet Kiguli, Sarah Naikoba, George W Pariyo and Stefan Peterson</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:21</dc:source>
			<dc:date>2008-06-21</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-21</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/20">
            
            <title>Developing evidence-based maternity care in Iran: 
a quality improvement study</title>
			<description>Background:
Current Iranian perinatal statistics indicate that maternity care continues to need improvement. In response, we implemented a multi-faceted intervention to improve the quality of maternity care at an Iranian Social Security Hospital. Using a before-and-after design our aim was to improve the uptake of selected evidence based practices and more closely attend to identified women's needs and preferences. 
Methods:
The major steps of the study were to (1) identify women's needs, values and preferences via interviews, (2) select through a process of professional consensus the top evidence-based clinical recommendations requiring local implementation (3) redesign care based on the selected evidence-based recommendations and women's views, and (4) implement the new care model. We measured the impact of the new care model on maternal satisfaction and caesarean birth rates utilising maternal surveys and medical record audit before and after implementation of the new care model.
Results:
Twenty women's needs and requirements as well as ten evidence-based clinical recommendations were selected as a basis for improving care. Following the introduction of the new model of care, women's satisfaction levels improved significantly on 16 of 20 items (p&lt; 0.0001) compared with baseline. Seventy-eight percent of studied women experienced care consistent with the new model and fewer women had a caesarean birth (30% compared with 42% previously).
Conclusions:
The introduction of a quality improvement care model improved compliance with evidence-based guidelines and was associated with an improvement in women's satisfaction levels and a reduction in rates of caesarean birth.</description>
			<link>http://www.biomedcentral.com/1471-2393/8/20</link>
			
			 	<dc:creator>Siamak Aghlmand, Feizollah Akbari, Aboulfath Lameei, Kazem Mohammad, Rhonda Small and Mohammad Arab</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:20</dc:source>
			<dc:date>2008-06-13</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-20</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-13</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/19">
            
            <title>Long-term effectiveness and costs of a brief self-management intervention in women with pregnancy-related low back pain after delivery</title>
			<description>Background:
Pregnancy-related low back pain is considered an important health problem and potentially leads to long-lasting pain and disability. Investigators draw particular attention to biomedical factors but there is growing evidence that psychosocial and social factors might be important. It prompted us to start a large cohort study (n = 7526) during pregnancy until one year after delivery and a nested randomized controlled intervention study in the Netherlands.
Methods:
A randomized controlled trial (n = 126) nested within a cohort study, of brief self-management techniques versus usual care for treatment of women with persisting non-specific pregnancy-related low back pain three weeks after delivery. Women in the intervention group were referred to a participating physiotherapist. Women in the usual care group were free to choose physiotherapy, guidance by a general practitioner or no treatment. Follow up took place at 3 months, 6 months and one year after delivery.Outcomes included change in limitations in activities (RDQ), pain (VAS), severity of main complaints (MC), global feeling of recovery (GPE), impact on participation and autonomy (IPA), pain-related fear (TSK), SF-36, EuroQol and a cost diary. For the outcome measures, series of mixed models were considered. For the outcome variable global perceived effect (GPE) a logistic regression analysis is performed.
Results:
Intention-to-treat outcomes showed a statistical significant better estimated regression coefficient RDQ -1.6 {-2.9;-0.5} associated with treatment, as well as better IPA subscale autonomy in self-care -1.0 {-1.9;-0.03} and TSK -2.4 {-3.8;-1.1} but were not clinical relevant over time. Average total costs in the intervention group were much lower than in usual care, primarily due to differences in utilization of sick leave but not statistically significant.
Conclusion:
Brief self-management techniques applied in the first 3 months after delivery may be a more viable first-line approach but further research is needed to draw inference on costs and to determine whether no care is a better option in the long term.Trial Registration[ISRCTN08477490]</description>
			<link>http://www.biomedcentral.com/1471-2393/8/19</link>
			
			 	<dc:creator>Caroline HG Bastiaenen, Rob A de Bie, Johan WS Vlaeyen, Mari&#235;lle EJB Goossens, Pieter Leffers, Pieter MJC Wolters, Janneke M Bastiaanssen, Piet A van den Brandt and Gerard GM Essed</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:19</dc:source>
			<dc:date>2008-05-30</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-19</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/18">
            
            <title>Multiplex ligation-dependent probe amplification versus karyotyping in prenatal diagnosis: the M.A.K.E. study</title>
			<description>Background:
In the past 30 years karyotyping was the gold standard for prenatal diagnosis of chromosomal aberrations in the fetus. Traditional karyotyping (TKT) has a high accuracy and reliability. However, it is labor intensive, the results take 14&#8211;21 days, the costs are high and unwanted findings such as abnormalities with unknown clinical relevance are not uncommon. These disadvantages challenged the practice of karyotyping. Multiplex ligation-dependent probe amplification (MLPA) is a new molecular genetic technique in prenatal diagnosis. Previous preclinical evidence suggests equivalence of MLPA and traditional karyotyping (TKT) regarding test performance.Methods/DesignThe proposed study is a multicentre diagnostic substitute study among pregnant women, who choose to have amniocentesis for the indication advanced maternal age and/or increased risk following prenatal screening test. In all subjects, both MLPA and karyotyping will be performed on the amniotic fluid sample. The primary outcome is diagnostic accuracy. Secondary outcomes will be maternal quality of life, women's preferences and costs. Analysis will be intention to treat and per protocol analysis. Quality of life analysis will be carried out within the study population. The study aims to include 4500 women.DiscussionThe study results are expected to help decide whether MLPA can replace traditional karyotyping for 'low-risk' pregnancies in terms of diagnostic accuracy, quality of life and women's preferences. This will be the first clinical study to report on all relevant aspects of the potential replacement.Trial RegistrationThe protocol is registered in the clinical trial register number ISRCTN47252164</description>
			<link>http://www.biomedcentral.com/1471-2393/8/18</link>
			
			 	<dc:creator>Elisabeth MA Boormans, Erwin Birnie, Hajo I Wildschut, Heleen G Schuring-Blom, Dick Oepkes, Carla AC van Oppen, Jan G Nijhuis, Merryn VE Macville, Angelique JA Kooper, Karin Huijsdens, Mari&#235;tte VJ Hoffer, Attie Go, Johan Creemers, Shama L Bhola, Katia M Bilardo, Ron Suijkerbuijk, Katelijne Bouman, Robert-Jan H Galjaard, Gouke J Bonsel and Jan MM van Lith</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:18</dc:source>
			<dc:date>2008-05-20</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-18</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/17">
            
            <title>Effect of iron content on the tolerability of prenatal multivitamins in pregnancy</title>
			<description>Background:
Gastrointestinal irritability can deter pregnant women from starting or continuing prenatal multivitamin supplementation. In a previous study, suboptimal tolerability was observed among pregnant women taking a large tablet (18 mm &#215; 8 mm &#215; 8 mm) multivitamin with high elemental iron content (60 mg as ferrous fumarate). The objective of the present study was to compare rates of adherence and reported adverse events among pregnant women who were randomized to commence supplementation with a small-tablet prenatal multivitamin, containing either low or high iron content.
Methods:
Pregnant women who called the Motherisk Program (Hospital for Sick Children, Toronto) and had not started taking or had discontinued any multivitamin due to adverse events were included in this prospective, randomized, open-label, 2-arm study. Women were randomized to take a small-size (16 mm &#215; 9 mm &#215; 4 mm), low elemental iron content (35 mg as ferrous fumarate) multivitamin ('35 mg' group); or a small-size (5 mm radius, 5 mm thickness), high elemental iron content (60 mg as ferrous sulphate) multivitamin ('60 mg' group). Follow-up interviews documented pill intake and adverse events. Rates of adherence and adverse events were compared between groups using chi-squared tests and Kaplan-Meier survival curves.
Results:
Of 167 randomized women, 92 in the '35 mg' group and 75 in the '60 mg' group were included in the analysis. Despite ideal conditions and regular follow-ups, mean adherence based on pill intake recall, in both groups was approximately 50%. No statistically significant difference was detected in proportions of women who actually started taking either multivitamin. Among those who started, no difference was detected in rates of adherence or reported adverse events.
Conclusion:
The present results suggest that iron content is not a major determinant of adherence to prenatal multivitamins. Combined with our previous study, tablet size may be the more definitive factor affecting adherence.</description>
			<link>http://www.biomedcentral.com/1471-2393/8/17</link>
			
			 	<dc:creator>Patricia Nguyen, Alejandro Nava-Ocampo, Amalia Levy, Deborah L O'Connor, Tom R Einarson, Anna Taddio and Gideon Koren</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:17</dc:source>
			<dc:date>2008-05-15</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-17</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/16">
            
            <title>Maternal mental health predicts risk of developmental problems at 3 years of age: follow up of a community based trial</title>
			<description>Background:
Undetected and untreated developmental problems can have a significant economic and social impact on society. Intervention to ameliorate potential developmental problems requires early identification of children at risk of future learning and behaviour difficulties. The objective of this study was to estimate the prevalence of risk for developmental problems among preschool children born to medically low risk women and identify factors that influence outcomes.
Methods:
Mothers who had participated in a prenatal trial were followed up three years post partum to answer a telephone questionnaire. Questions were related to child health and development, child care, medical care, mother's lifestyle, well-being, and parenting style. The main outcome measure was risk for developmental problems using the Parents' Evaluation of Developmental Status (PEDS).
Results:
Of 791 children, 11% were screened by the PEDS to be at high risk for developmental problems at age three. Of these, 43% had previously been referred for assessment. Children most likely to have been referred were those born preterm. Risk factors for delay included: male gender, history of ear infections, a low income environment, and a mother with poor emotional health and a history of abuse. A child with these risk factors was predicted to have a 53% chance of screening at high risk for developmental problems. This predicted probability was reduced to 19% if the child had a mother with good emotional health and no history of abuse.
Conclusion:
Over 10% of children were identified as high risk for developmental problems by the screening, and more than half of those had not received a specialist referral. Risk factors for problems included prenatal and perinatal maternal and child factors. Assessment of maternal health and effective screening of child development may increase detection of children at high risk who would benefit from early intervention.Trial registrationCurrent Controlled Trials ISRCTN64070727</description>
			<link>http://www.biomedcentral.com/1471-2393/8/16</link>
			
			 	<dc:creator>Suzanne C Tough, Jodi E Siever, Shirley Leew, David W Johnston, Karen Benzies and Dawne Clark</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:16</dc:source>
			<dc:date>2008-05-06</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-16</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/15">
            
            <title>Inadequate prenatal care and its association with adverse pregnancy outcomes: A comparison of indices</title>
			<description>Background:
The objectives of this study were to determine rates of prenatal care utilization in Winnipeg, Manitoba, Canada from 1991 to 2000; to compare two indices of prenatal care utilization in identifying the proportion of the population receiving inadequate prenatal care; to determine the association between inadequate prenatal care and adverse pregnancy outcomes (preterm birth, low birth weight [LBW], and small-for-gestational age [SGA]), using each of the indices; and, to assess whether or not, and to what extent, gestational age modifies this association.
Methods:
We conducted a population-based study of women having a hospital-based singleton live birth from 1991 to 2000 (N = 80,989). Data sources consisted of a linked mother-baby database and a physician claims file maintained by Manitoba Health. Rates of inadequate prenatal care were calculated using two indices, the R-GINDEX and the APNCU. Logistic regression analysis was used to determine the association between inadequate prenatal care and adverse pregnancy outcomes. Stratified analysis was then used to determine whether the association between inadequate prenatal care and LBW or SGA differed by gestational age.
Results:
Rates of inadequate/no prenatal care ranged from 8.3% using APNCU to 8.9% using R-GINDEX. The association between inadequate prenatal care and preterm birth and LBW varied depending on the index used, with adjusted odds ratios (AOR) ranging from 1.0 to 1.3. In contrast, both indices revealed the same strength of association of inadequate prenatal care with SGA (AOR 1.4). Both indices demonstrated heterogeneity (non-uniformity) across gestational age strata, indicating the presence of effect modification by gestational age.
Conclusion:
Selection of a prenatal care utilization index requires careful consideration of its methodological underpinnings and limitations. The two indices compared in this study revealed different patterns of utilization of prenatal care, and should not be used interchangeably. Use of these indices to study the association between utilization of prenatal care and pregnancy outcomes affected by the duration of pregnancy should be approached cautiously.</description>
			<link>http://www.biomedcentral.com/1471-2393/8/15</link>
			
			 	<dc:creator>Maureen I Heaman, Christine V Newburn-Cook, Chris G Green, Lawrence J Elliott and Michael E Helewa</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:15</dc:source>
			<dc:date>2008-05-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2393/8/14">
            
            <title>MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes</title>
			<description>Background:
The Medical Research Council (MRC) ORACLE trial evaluated the use of co-amoxiclav 375 mg and/or erythromycin 250 mg in women presenting with preterm rupture of membranes (PROM) ORACLE I or in spontaneous preterm labour (SPL) ORACLE II using a factorial design. The results showed that for women with a singleton baby with PROM the prescription of erythromycin is associated with improvements in short term neonatal outcomes, although co-amoxiclav is associated with prolongation of pregnancy, a significantly higher rate of neonatal necrotising enterocolitis was found in these babies. Prescription of erythromycin is now established practice for women with PROM. For women with SPL antibiotics demonstrated no improvements in short term neonatal outcomes and are not recommended treatment. There is evidence that both these conditions are associated with subclinical infection so perinatal antibiotic administration may reduce the risk of later disabilities, including cerebral palsy, although the risk may be increased through exposure to inflammatory cytokines, so assessment of longer term functional and educational outcomes is appropriate.
Methods:
The MRC ORACLE Children's Study will follow up UK children at age 7 years born to 4809 women with PROM and the 4266 women with SPL enrolled in the earlier ORACLE trials. We will use a parental questionnaire including validated tools to assess disability and behaviour. We will collect the frequency of specific medical conditions: cerebral palsy, epilepsy, respiratory illness including asthma, diabetes, admission to hospital in last year and other diseases, as reported by parents.National standard test results will be collected to assess educational attainment at Key Stage 1 for children in England.DiscussionThis study is designed to investigate whether or not peripartum antibiotics improve health and disability for children at 7 years of age.Trial registrationThe ORACLE Trial and Children Study is registered in the Current Controlled Trials registry. ISCRTN 52995660</description>
			<link>http://www.biomedcentral.com/1471-2393/8/14</link>
			
			 	<dc:creator>Sara Kenyon, Peter Brocklehurst, David Jones, Neil Marlow, Alison Salt and David Taylor</dc:creator>
			
			<dc:source>BMC Pregnancy and Childbirth 2008, 8:14</dc:source>
			<dc:date>2008-04-24</dc:date>
			<dc:identifier>doi:10.1186/1471-2393-8-14</dc:identifier>
			
			
							
					<prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
					
			
							
					<prism:issn>1471-2393</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
